Related Experiment Video

Updated: Jun 13, 2025

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.1K

A new scoring system to predict survival in elderly advanced stage Hodgkin lymphoma patients

Özgür Mehtap1, Tayfur Toptas2, Mehmet S Dal3

  • 1Department of Hematology, Kocaeli University, Kocaeli, Turkiye.

Leukemia & Lymphoma
|September 13, 2024
PubMed

Insights

A new scoring system, Hodgkin's Lymphoma Early Death in the Elderly within 12 months (HEDEL12), predicts survival in elderly classical Hodgkin lymphoma patients. This tool identifies key factors for early mortality, aiding clinical decisions.

Area of Science:

  • Oncology
  • Geriatric Medicine
  • Biostatistics

Background:

  • Prognostic scoring systems are often not optimized for elderly patients with classical Hodgkin lymphoma (cHL).
  • Accurate survival prediction is crucial for tailoring treatment and improving outcomes in this specific demographic.
  • The need for a dedicated prognostic tool for elderly cHL patients is evident.

Purpose of the Study:

  • To develop and validate a novel prognostic scoring system for elderly patients diagnosed with classical Hodgkin lymphoma.
  • To identify independent predictors of early mortality (within 12 months) in this patient population.
  • To create a tool that assists in predicting overall survival for advanced-stage cHL patients.

Main Methods:

  • Development of a prognostic score using a derivation cohort (DC) with 97 variables.
  • Identification of independent predictors through statistical analysis.
  • Validation of the developed score (HEDEL12) using internal (IVC) and external (EVC) validation cohorts, totaling 286 patients.

Main Results:

  • The HEDEL12 score identified female sex, low albumin levels (<3.5 g/dL), and ECOG scores of 2-4 as independent predictors of early death.
  • In the derivation cohort, 38 out of 178 patients died within 12 months, with a 12-month overall survival of 78.6%.
  • Validated HEDEL12 scores of 0-1 correlated with high 12-month overall survival rates of 89.8% (IVC) and 91.0% (EVC).

Conclusions:

  • The HEDEL12 scoring system effectively predicts survival in elderly patients with advanced-stage classical Hodgkin lymphoma.
  • This tool can aid clinicians in assessing prognosis and potentially guiding therapeutic strategies for this vulnerable patient group.
  • The HEDEL12 score offers a valuable prognostic assessment for elderly cHL patients, addressing a gap in current scoring systems.

Keywords:
Elderly hodgkin lymphomaadvanced stageprognostic scoring

More Related Videos

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

226
Digital Analysis of Immunostaining of ZW10 Interacting Protein in Human Lung Tissues07:40

Digital Analysis of Immunostaining of ZW10 Interacting Protein in Human Lung Tissues

Published on: May 1, 2019

5.4K

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
334
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
162
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
111
Actuarial Approach01:20

Actuarial Approach

The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
68